Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides.
Lipoxygenase is suggested to be involved in the early event of atherosclerosis by inducing plasma low-density lipoprotein (LDL) oxidation in the subendothelial space of the arterial wall. Since flavonoids such as quercetin are recognized as lipoxygenase inhibitors and they occur mainly in the glycoside form, we assessed the effect of quercetin and its glycosides (quercetin 3-O-beta-glucopyranoside, Q3G; quercetin 4'-O-beta-glucopyranoside, Q4'G; quercetin 7-O-beta-glucopyranoside, Q7G) on rabbit reticulocyte 15-lipoxygenase (15-LOX)-induced human LDL lipid peroxidation and compared it with the inhibition obtained by ascorbic acid and alpha-tocopherol, the main water-soluble and lipid-soluble antioxidants in blood plasma, respectively. Quercetin inhibited the formation of cholesteryl ester hydroperoxides (CE-OOH) and endogenous alpha-tocopherol consumption effectively throughout the incubation period of 6 h. Ascorbic acid exhibited an effective inhibition only in the initial stage and LDL preloaded with fivefold alpha-tocopherol did not affect the formation of CE-OOH compared with the native LDL. CE-OOH formation was inhibited by both quercetin and quercetin monoglucosides in a concentration-dependent manner. Quercetin, Q3G, and Q7G exhibited a higher inhibitory effect than Q4'G (IC50: 0.3-0.5 microM for quercetin, Q3G, and Q7G and 1.2 microM for Q4'G). While endogenous alpha-tocopherol was completely depleted after 2 h of LDL oxidation, quercetin, Q7G, and Q3G prevented the consumption of alpha-tocopherol. Quercetin and its monoglucosides were also exhausted during the LDL oxidation. These results indicate that quercetin glycosides as well as its aglycone are capable of inhibiting lipoxygenase-induced LDL oxidation more efficiently than ascorbic acid and alpha-tocopherol.
Luiz da Silva
E
E
National Food Research Institute, Ministry of Agriculture, Forestry, and Fisheries, Ibaraki, Japan.
Tsushida
T
T
Terao
J
J
D000818:Animals; D001093:Arachidonate 15-Lipoxygenase / Q000097:blood*; D005960:Glucosides / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D015227:Lipid Peroxidation; D008077:Lipoproteins, LDL / Q000097:blood*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D008322:Mammals; D010084:Oxidation-Reduction; D011794:Quercetin / Q000031:analogs & derivatives* / Q000494:pharmacology; D011817:Rabbits; D012156:Reticulocytes / Q000201:enzymology*; D014810:Vitamin E / Q000378:metabolism
D005960:Glucosides; D008077:Lipoproteins, LDL; D016859:Lipoxygenase Inhibitors; C110310:quercetin 4'-O-glucopyranoside; C110311:quercetin 7-O-glucopyranoside; D014810:Vitamin E; D011794:Quercetin; D001093:Arachidonate 15-Lipoxygenase; C110309:quercetin 3-O-glucopyranoside